Loxo
Loxo Oncology, a prominent player in the biopharmaceutical industry, is headquartered in the United States and focuses on the development of targeted therapies for cancer treatment. Founded in 2013, the company has made significant strides in precision medicine, particularly in the field of oncology, with a commitment to addressing unmet medical needs. Loxo Oncology is renowned for its innovative approach to drug development, offering unique therapies that target specific genetic mutations in tumours. Their core products, including the well-regarded Vitrakvi (larotrectinib), exemplify their dedication to personalised medicine, setting them apart in a competitive market. With a strong presence in the US and expanding operations globally, Loxo has established itself as a leader in the oncology sector, achieving notable milestones in clinical trials and regulatory approvals.
DitchCarbon Score
How does Loxo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Loxo's score of 21 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Loxo's reported carbon emissions
As of the latest available data, Loxo has not disclosed specific carbon emissions figures for recent years, including 2017. The company has not provided information on Scope 1, 2, or 3 emissions, nor have they outlined any specific reduction targets or achievements. Loxo's commitment to addressing climate change remains unclear, as there are no documented reduction initiatives or climate pledges available. The absence of detailed emissions data and reduction strategies suggests that Loxo may still be in the early stages of developing a comprehensive climate action plan. In the broader industry context, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate their carbon footprints. However, without specific commitments or data, Loxo's position in this regard remains ambiguous.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Loxo is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
